PEPG - PepGen Inc.
NEXT EARNINGS:
Feb 23, 2026
(in 13 days)
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$13.00
DETAILS
HIGH:
$18.00
LOW:
$9.00
MEDIAN:
$12.00
CONSENSUS:
$13.00
UPSIDE:
135.93%
Market Cap:
378.80M
Volume:
1,297,772
Avg Volume:
732,932
52 Week Range:
0.88-7.8
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.91
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
79
IPO Date:
2022-05-06
EPS (TTM):
-2.85
P/E Ratio:
-1.33
Revenue (TTM):
N/A
Total Assets:
150.88M
Total Debt:
18.66M
Cash & Equiv:
49.42M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-67.5%
Debt/Equity:
0.16
Track Record
Statements >| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | (89.98M) | (78.63M) | (69.10M) | (27.28M) | (1.89M) | (1.35M) |
| EPS | -2.85 | -3.30 | -4.42 | -1.22 | -0.53 | -0.06 |
| Total Assets | 150.88M | 143.05M | 217.44M | 143.64M | 10.64M | 4.19M |
| Total Debt | 18.66M | 20.10M | 24.53M | N/A | N/A | N/A |
| Cash & Equivalents | 49.42M | 80.77M | 181.75M | 132.90M | 9.78M | 3.49M |
| Operating Cash Flow | (82.37M) | (69.00M) | (59.27M) | (22.60M) | (1.65M) | (885,000) |
| Free Cash Flow | (82.87M) | (71.60M) | (63.02M) | (23.10M) | (1.66M) | (914,000) |
| FCF per Share | -2.62 | -3.01 | -4.03 | -1.03 | -0.22 | -0.04 |
| Book Value | 118.62M | 108.42M | 179.63M | 133.09M | 9.77M | 3.87M |
| Cash & ST Investments | 120.19M | 110.41M | 181.75M | 132.90M | 9.78M | 3.49M |
| ROC Equity | -0.76 | -0.73 | -0.38 | -0.20 | -0.19 | -0.35 |